AGTR1 and metabolic syndrome: Further research to understand PVAT in the SHRSP.ZF model may identify novel therapeutic strategies to regulate AT1 receptor signaling in PVAT and protect against arterial PVAT dysfunction while reducing development of cardiovascular diseases related to MetS.